By: Benzinga
Synergy Pharmaceuticals Shareholders Approve Merger with Callisto Pharmaceuticals
Synergy Pharmaceuticals (NASDAQ: SGYP ) ("Synergy") today announced that it convened its annual meeting of stockholders yesterday and it has received the necessary approvals from its stockholders to authorize Synergy's merger with Callisto Pharmaceuticals (NASDAQ: CLSP ) pursuant to the previously announced Agreement and Plan of Merger, dated
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here